Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Inventory (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Inventory readings, the most recent being $36.0 million for Q4 2025.

  • On a quarterly basis, Inventory fell 8.21% to $36.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.0 million, a 8.21% decrease, with the full-year FY2025 number at $36.0 million, down 8.21% from a year prior.
  • Inventory hit $36.0 million in Q4 2025 for Treace Medical Concepts, down from $41.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $43.6 million in Q3 2024 to a low of $7.4 million in Q1 2021.
  • Median Inventory over the past 5 years was $27.7 million (2023), compared with a mean of $26.1 million.
  • Biggest five-year swings in Inventory: surged 102.65% in 2023 and later dropped 8.21% in 2025.
  • Treace Medical Concepts' Inventory stood at $10.6 million in 2021, then soared by 83.03% to $19.3 million in 2022, then skyrocketed by 51.29% to $29.2 million in 2023, then skyrocketed by 34.23% to $39.3 million in 2024, then fell by 8.21% to $36.0 million in 2025.
  • The last three reported values for Inventory were $36.0 million (Q4 2025), $41.4 million (Q3 2025), and $42.4 million (Q2 2025) per Business Quant data.